Subsequent studies revealed that up-regulation of RPL6 protected gastric cancer cells from adriamycin-induced apoptosis and enhanced the resistance of gastric cancer cells to multiple chemotherapeutic drugs, including vincristine, adriamycin, etopside, cisplatin and 5-fludrouracil [13]. The gene discussed is RPL6; the disease is gastric cancer.